how long have people been using semaglutide Two-year effects of in adults with overweight or obesity: the STEP 5 trial Results we LOVE! These results

Foralumab, the only fully human anti-CD3 monoclonal antibody (mAb) currently in clinical development, binds to the T cell receptor and dampens inflammation by modulating T cell function, thereby suppressing effector features in multiple immune cell subsets

Stay active and track your diet: Exercise and mindful eating are essential for maintaining results after GLP-1 treatment

BMS Psychiatry

Peroxiredoxin II (Prx II) is an efficient antioxidant enzyme, which were highly expressed in skin tissues of psoriasis patient

Wed Love to Hear from You

Novo Nordisk achieved oral administration by combining semaglutide and SNAC, marking a milestone in the global oral product schedule as the first orally approved GLP-1 receptor agonist in the world